Cardinal Health (CAH) Laps the Stock Market: Here's Why

Cardinal Health (CAH) gained 2.41% in recent trading, outperforming the S&P 500. The prescription drug distributor is expected to report earnings of $2.92 per share on November 5, 2026, representing 14.51% year-over-year growth, with revenue projected at $66.96 billion. The stock holds a Zacks Rank #2 (Buy) rating, though it trades at a premium valuation with a Forward P/E of 19.75 compared to its industry average of 17.67.